⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 19, 2025ImmunotherapyOpen Access

Cell and gene therapy in Germany: three decades of advanced technologies

Amit Sharma Andreas Neubauer Burghardt Wittig Ingo G.H. Schmidt‐Wolf

View Full Paper

Ask AI

Bookmark

Share

Key Points

Germany has seen significant advancements in gene therapy over three decades, improving cancer treatment options and related outcomes.
Key technologies include CRISPR-Cas9 and immune checkpoint inhibitors, which significantly enhance therapeutic strategies across various cancers.
Observational analysis highlights breakthroughs in cytokine-induced killer cell therapy, showcasing its role in modern cancer treatments.
The findings emphasize the expanding role of cellular immunotherapies, which may become prominent in future treatment protocols for cancer patients.

Implication

This review discusses advancements in gene therapy and cellular immunotherapies in Germany, highlighting significant technologies.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Sharma et al. (2025) studied this question.

synapsesocial.com/papers/68af4551ad7bf08b1ead36eb https://doi.org/10.1080/1750743x.2025.2549241

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The German National Strategy for Gene- and Cell-Based Therapies: Generating Impact by Employing a Novel Multi-Stakeholder ApproachOriginal Research · 2026
2Cell and Gene Therapy: The Present and Future of Medicine2024
3The state of cell and gene therapy in 2023Human Clinical Trial · 2023 · 148 citations
4Cell and Gene Therapy: Transforming Treatment Paradigms for Patient‐Centric Care2025 · 3 citations
5Gene and Cell Therapy in Regenerative MedicineOriginal Research · 2026

More related papers

Cell and Gene Therapy Products based on Gene Editing: Clinical Advances, Process Development, And Standardization Prospects2026
The New Wave of Gene and Cell Therapies Across Diseases2026
Advances in cellular therapy for cancer: vector design and genome editing2026

More from Immunotherapy

Baseline circulating immunophenotype as a predictor of immune-related adverse events in NSCLC patients treated with immune checkpoint inhibitorsSun,
Circulating and tumor microenvironment immunomarkers associate with immunotherapy efficacy in advanced bladder urothelial carcinoma: an exploratory multicenter study integrating genomic and immunophenotypic profilingFri,